Nothing Special   »   [go: up one dir, main page]

BR112015003931A2 - composição de teste para detecção de cãncer - Google Patents

composição de teste para detecção de cãncer

Info

Publication number
BR112015003931A2
BR112015003931A2 BR112015003931A BR112015003931A BR112015003931A2 BR 112015003931 A2 BR112015003931 A2 BR 112015003931A2 BR 112015003931 A BR112015003931 A BR 112015003931A BR 112015003931 A BR112015003931 A BR 112015003931A BR 112015003931 A2 BR112015003931 A2 BR 112015003931A2
Authority
BR
Brazil
Prior art keywords
test composition
cancer detection
cancer
detection
test
Prior art date
Application number
BR112015003931A
Other languages
English (en)
Inventor
Chang Chi-Feng
Wang Huei-Jen
Liou Yu-Ligh
Original Assignee
Istat Biomedical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istat Biomedical Co Ltd filed Critical Istat Biomedical Co Ltd
Publication of BR112015003931A2 publication Critical patent/BR112015003931A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2527/00Reactions demanding special reaction conditions
    • C12Q2527/143Concentration of primer or probe
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/166Oligonucleotides used as internal standards, controls or normalisation probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
BR112015003931A 2012-08-28 2012-08-28 composição de teste para detecção de cãncer BR112015003931A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2012/080655 WO2014032227A1 (zh) 2012-08-28 2012-08-28 一种癌症筛检的检验组合物

Publications (1)

Publication Number Publication Date
BR112015003931A2 true BR112015003931A2 (pt) 2017-08-08

Family

ID=50182350

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015003931A BR112015003931A2 (pt) 2012-08-28 2012-08-28 composição de teste para detecção de cãncer

Country Status (11)

Country Link
US (1) US20150337386A1 (pt)
EP (1) EP2891719A4 (pt)
JP (1) JP2015528286A (pt)
KR (1) KR20150041148A (pt)
AU (1) AU2012388638B2 (pt)
BR (1) BR112015003931A2 (pt)
CA (1) CA2882185A1 (pt)
HK (1) HK1210227A1 (pt)
PH (1) PH12015500324B1 (pt)
SG (1) SG11201501115VA (pt)
WO (1) WO2014032227A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6312861B2 (ja) * 2014-05-19 2018-04-18 ザ カトリック ユニバーシティ オブ コリア インダストリー−アカデミック コーオペレイション ファウンデーション がん発症の予測、早期診断、及び治療剤としてのnkx6.3の用途
EP3344783A4 (en) 2015-08-31 2019-07-17 The United States Of America As Represented By The Secretary Of The Army PROCESS FOR THE MOLECULAR CHARACTERIZATION OF CERVICAL CELL SAMPLES
CN107937520B (zh) * 2017-11-02 2021-07-27 中山大学附属第八医院(深圳福田) 与结直肠癌相关的分子标记物、抑制剂、试剂盒和药剂
US11396679B2 (en) 2019-05-31 2022-07-26 Universal Diagnostics, S.L. Detection of colorectal cancer
US11001898B2 (en) 2019-05-31 2021-05-11 Universal Diagnostics, S.L. Detection of colorectal cancer
US11898199B2 (en) 2019-11-11 2024-02-13 Universal Diagnostics, S.A. Detection of colorectal cancer and/or advanced adenomas
WO2022002424A1 (en) 2020-06-30 2022-01-06 Universal Diagnostics, S.L. Systems and methods for detection of multiple cancer types
CN114561461B (zh) * 2020-11-27 2024-01-30 广州达健生物科技有限公司 用于检测宫颈癌的组合物及其试剂盒和应用
CN113355415B (zh) * 2021-06-04 2022-06-10 武汉艾米森生命科技有限公司 用于食管癌诊断或辅助诊断的检测试剂及试剂盒
CN118685522B (zh) * 2024-08-26 2024-11-19 湖南宏雅基因技术有限公司 一种用于口腔癌食管癌检测的生物标志物组合、引物探针组合物及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331393B1 (en) * 1999-05-14 2001-12-18 University Of Southern California Process for high-throughput DNA methylation analysis
WO2002018632A2 (de) * 2000-09-01 2002-03-07 Epigenomics Ag Verfahren zur bestimmung des methylierungsgrades von bestimmten cytosinen in genomischer dna im sequenzkontext 5'-cpg-3'
US20040058356A1 (en) * 2001-03-01 2004-03-25 Warren Mary E. Methods for global profiling gene regulatory element activity
WO2007050706A2 (en) * 2005-10-27 2007-05-03 University Of Missouri-Columbia Dna methylation biomarkers in lymphoid and hematopoietic malignancies
JP5613971B2 (ja) * 2006-05-24 2014-10-29 国立大学法人九州大学 病原性リステリア菌の検出方法
TW200831900A (en) 2007-01-23 2008-08-01 Hong-Zheng Lai Cancer screen method
US20080213781A1 (en) * 2007-02-15 2008-09-04 Baden Jonathan F Methods of detecting methylation patterns within a CpG island
US7820386B2 (en) 2007-06-15 2010-10-26 National Defense Medical Center Cancer screening method
CN101831490A (zh) * 2009-03-12 2010-09-15 上海市第八人民医院 一种利用pax1和cdh1基因甲基化检测宫颈癌的方法和试剂盒
TWI385252B (zh) 2009-04-16 2013-02-11 Nat Defense Medical Ct 一種癌症篩檢的方法
US8048634B2 (en) * 2009-08-18 2011-11-01 National Defense Medical Center Cancer screening method

Also Published As

Publication number Publication date
CA2882185A1 (en) 2014-03-06
WO2014032227A1 (zh) 2014-03-06
PH12015500324A1 (en) 2015-04-06
AU2012388638A1 (en) 2015-03-19
EP2891719A1 (en) 2015-07-08
JP2015528286A (ja) 2015-09-28
AU2012388638B2 (en) 2017-08-17
SG11201501115VA (en) 2015-04-29
PH12015500324B1 (en) 2015-04-06
KR20150041148A (ko) 2015-04-15
EP2891719A4 (en) 2016-06-15
US20150337386A1 (en) 2015-11-26
HK1210227A1 (en) 2016-04-15

Similar Documents

Publication Publication Date Title
BR112013031019A2 (pt) teste diagnóstico molecular para câncer
HK1214633A1 (zh) 癌症的分子診斷測試
BR112015003931A2 (pt) composição de teste para detecção de cãncer
BR112014027465A2 (pt) teste de imunosseleção de multiplex.
BR112015002588A2 (pt) composição de coloração de antocianina
BR112014031435A2 (pt) teste randomizado dentro de execução transacional
DE112012005650T8 (de) Risikomesssystem
GB201223166D0 (en) Test strip
IL244471A0 (en) Molecular diagnostic test for esophageal cancer
EP2929435A4 (en) RAID INSPECTOR
BR112015001100A2 (pt) método de detecção de câncer
HUE036577T2 (hu) Kalibrációs eljárás reagenskártya analizátorhoz
FI20126266A (fi) Pehmopaperin mittaus
EP2748608A4 (en) LUNG CANCER TESTS
EP2851688A4 (en) MARKER FOR THE DETECTION OF PANCREATIC CANCER
EP2878951A4 (en) ANALYTICAL DEVICE
FI20125887A (fi) Järjestely biosignaalin mittaamiseksi
GB2506424B (en) Target clearance measurement device
BR112014025875A2 (pt) Método de medição
HK1202621A1 (en) Analyte meter for test strips
EP2821795A4 (en) SAMPLE PRETREATMENT SYSTEM
HK1215730A1 (zh) 樣品測試裝置
DK3043589T3 (da) Målerapportering
DK3656313T3 (da) Vakuumunderstøttet biopsiindretning
BR112014017097A2 (pt) sonda de reflexão

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2529 DE 25-06-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.